MarkS. Gold
Impact in
-
- Neuropeptides and Animal Physiology
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Papers in
-
- Genetic Neurodegenerative Diseases 1
-
- Substance Abuse Treatment and Outcomes 2
- Co-authors
- H D Kleber (1 shared paper)D. Eugene Redmond (1 shared paper)Arnold M. Washton (1 shared paper)A.L.C. Pottash (1 shared paper)Candace Hodgkins (1 shared paper)Kimberly Frost-Pineda (1 shared paper)James A. Cocores (1 shared paper)Louis B. Schlesinger (1 shared paper)
- Journals
- Journal of Addictive Diseases (1 paper)Psychosomatics (1 paper)The Lancet (1 paper)The International Journal of Psychiatry in Medicine (2 papers)PubMed (2 papers)
- Partner nations
- United StatesIsraelHungary
In The Last Decade
MarkS. Gold
7 papers receiving 572 citations
MarkS. Gold's Hit Papers
Peers
Comparison fields: 5 of 71
- Cellular and Molecular Neuroscience 337
- Anesthesiology and Pain Medicine 56
- Behavioral Neuroscience 37
- Critical Care and Intensive Care Medicine 28
- Psychiatry and Mental health 65
Countries citing papers authored by MarkS. Gold
This map shows the geographic impact of MarkS. Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MarkS. Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MarkS. Gold more than expected).
Fields of papers citing papers by MarkS. Gold
This network shows the impact of papers produced by MarkS. Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MarkS. Gold. The network helps show where MarkS. Gold may publish in the future.
Co-authors
The 18 scholars most cited alongside MarkS. Gold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS Hit paper breakdown → | 1978 | 592 |
| 2 | 1987 | 22 | |
| 3 | 1984 | 18 | |
| 4 | 2007 | 15 | |
| 5 | 2021 | 6 | |
| 6 | How to Combat the Global Opioid Crisis. | 2023 | 6 |
| 7 | 1987 | 5 |
About MarkS. Gold
MarkS. Gold is a scholar working on Cellular and Molecular Neuroscience, Epidemiology, Public Health, Environmental and Occupational Health, Pharmacology and Pathology and Forensic Medicine, having authored 7 papers that have together received 664 indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (2 papers), Substance Abuse Treatment and Outcomes (2 papers), Mental Health Treatment and Access (1 paper), Child and Adolescent Psychosocial and Emotional Development (1 paper), Genetic Neurodegenerative Diseases (1 paper), Pain Management and Opioid Use (1 paper), Neurology and Historical Studies (1 paper) and Digital Mental Health Interventions (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (337 citations), Anesthesiology and Pain Medicine (56 citations), Behavioral Neuroscience (37 citations), Critical Care and Intensive Care Medicine (28 citations) and Psychiatry and Mental health (65 citations). MarkS. Gold has collaborated with scholars based in United States, Israel and Hungary. Frequent co-authors include H D Kleber, D. Eugene Redmond, Arnold M. Washton, A.L.C. Pottash, Candace Hodgkins, Kimberly Frost-Pineda, James A. Cocores, Louis B. Schlesinger, Rajendra D. Badgaiyan and Igor Elman. Their work appears in journals such as Journal of Addictive Diseases, Psychosomatics, The Lancet, The International Journal of Psychiatry in Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.